Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03272529 · ClinicalTrials.gov registry record

Simulated Rehearsal for Percutaneous Nephrolithotomy

A clinical trial of Nephrolithotomy, sponsored by University of Rochester.

Completed
Registry status
36
Enrollment target
1
Study location

NCT03272529 is a study of Nephrolithotomy that has completed, run by University of Rochester. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03272529, a study of Nephrolithotomy, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
36 participants
Enrollment target
1
Study location

Study Summary

Surgical simulation provides opportunities for surgeons to practice specific skills, prior to performing complex tasks on patients, with the goal of reducing potential errors and providing a safer procedure for the patient. The investigators will use a novel approach to simulation (patient-specific rehearsals) i.e., practice a short time prior to the live event that uses gel models of organs created by a 3D printer, and that are specific to each patient versus models that represent an ideal training model. The investigators' overarching goals are to improve patient outcomes by developing the best platform for surgeons to efficiently enhance performance prior to live surgery.

Conditions Studied

Interventions

  • OTHER Patient-specific simulated rehearsals
  • OTHER Idealized simulated rehearsals
  • OTHER Standard simulation

Study Locations (1)

New York

  • University of Rochester Medical Center - Rochester

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2018-04-10
Est. Completion 2023-01-31

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT03272529

The ClinicalTrials.gov registry entry for NCT03272529 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nephrolithotomy appearing as the primary indexed condition, and to 3 interventions - of which Patient-specific simulated rehearsals is the first listed.

NCT03272529 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03272529 about?

NCT03272529 is a clinical study titled "Simulated Rehearsal for Percutaneous Nephrolithotomy". Surgical simulation provides opportunities for surgeons to practice specific skills, prior to performing complex tasks on patients, with the goal of reducing potential errors and providing a safer procedure for the patient. The investigators will use a novel approach to simulation (patient-specific ...

What is the current status of trial NCT03272529?

This trial is currently completed. The enrollment target is 36 participants. The study started on 2018-04-10. Estimated completion is 2023-01-31.

What conditions does trial NCT03272529 study?

This clinical trial studies the following conditions: Nephrolithotomy.

What interventions are being tested in trial NCT03272529?

The interventions under investigation include: Patient-specific simulated rehearsals (OTHER), Idealized simulated rehearsals (OTHER), Standard simulation (OTHER).

Who is sponsoring clinical trial NCT03272529?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03272529 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nephrolithotomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.